You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-CD79a antibody (ab5691)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Overview

Product name

Anti-CD79a antibody
See all CD79a products (16) ...

Description

Rabbit polyclonal to CD79a

Tested applications

IHC-P, ELISA, WBmore details

Cross reactivity

Reacts with

Human

Immunogen

Synthetic peptide (Human).

Positive control

Human tonsil sections. Spleen.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: 0.02% Sodium Azide
Constituents: PBS, pH 7.4

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Clonality

Polyclonal

Isotype

IgG

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD79a antibody (ab5691)Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD79a antibody (ab5691) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab5691 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • ShowHide1 Image

    IHC-P

     IHC-P: 1/100. Perform he...Read more →

    IHC-P: 1/100. Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

  • ShowHide

    ELISA

     ELISA: Use a concentrati...Read more →

    ELISA: Use a concentration of 0.1 - 1 µg/ml.

  • ShowHide

    WB

     WB: Use a concentration ...Read more →

    WB: Use a concentration of 0.5 - 2 µg/ml. Predicted molecular weight: 25 kDa.

Target

Function

Required in cooperation with CD79B for initiation of the signal transduction cascade activated by binding of antigen to the B-cell antigen receptor complex (BCR) which leads to internalization of the complex, trafficking to late endosomes and antigen presentation. Also required for BCR surface expression and for efficient differentiation of pro- and pre-B-cells. Stimulates SYK autophosphorylation and activation. Binds to BLNK, bringing BLNK into proximity with SYK and allowing SYK to phosphorylate BLNK. Also interacts with and increases activity of some Src-family tyrosine kinases. Represses BCR signaling during development of immature B cells.

Tissue specificity

B-cells.

Involvement in disease

Defects in CD79A are the cause of agammaglobulinemia type 3 (AGM3) [MIM:613501]. It is a primary immunodeficiency characterized by profoundly low or absent serum antibodies and low or absent circulating B cells due to an early block of B-cell development. Affected individuals develop severe infections in the first years of life. Note=Two different mutations, one at the splice donor site of intron 2 and the other at the splice acceptor site for exon 3, have been identified. Both mutations give rise to a truncated protein.

Sequence similarities

Contains 1 Ig-like C2-type (immunoglobulin-like) domain.
Contains 1 ITAM domain.

Post-translational
modifications

Phosphorylated on tyrosine, serine and threonine residues upon B-cell activation. Phosphorylation of tyrosine residues by Src-family kinases is an early and essential feature of the BCR signaling cascade. The phosphorylated tyrosines serve as docking sites for SH2-domain containing kinases, leading to their activation which in turn leads to phosphorylation of downstream targets. Phosphorylation of serine and threonine residues may prevent subsequent tyrosine phosphorylation.

Cellular localization

Cell membrane. Following antigen binding, the BCR has been shown to translocate from detergent-soluble regions of the cell membrane to lipid rafts although signal transduction through the complex can also occur outside lipid rafts.

Target information above from: UniProt accessionP11912 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • B cell antigen receptor complex associated protein alpha chain antibody
  • B cell antigen receptor complex associated protein alpha chain precursor antibody
  • B Lymphocyte Specific MB1 Protein antibody
  • B-cell antigen receptor complex-associated protein alpha chain antibody
  • CD 79a antibody
  • CD79a antibody
  • CD79A antigen antibody
  • CD79A antigen immunoglobulin associated alpha antibody
  • CD79a molecule immunoglobulin associated alpha antibody
  • CD79A_HUMAN antibody
  • Ig alpha antibody
  • Ig-alpha antibody
  • IGA antibody
  • Immunoglobulin Associated Alpha antibody
  • Ly54 antibody
  • MB 1 antibody
  • MB 1 membrane glycoprotein antibody
  • MB-1 membrane glycoprotein antibody
  • MB1 antibody
  • MB1 membrane glycoprotein antibody
  • Membrane bound immunoglobulin associated protein antibody
  • Membrane-bound immunoglobulin-associated protein antibody
  • Surface IgM associated protein antibody
  • Surface IgM-associated protein antibody
see all

Anti-CD79a antibody images:

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD79a antibody (ab5691)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD79a antibody (ab5691)

Human tonsil stained with ab5691.

References for Anti-CD79a antibody (ab5691)

This product has been referenced in:

  • Cuttica MJ  et al. Perivascular T-cell infiltration leads to sustained pulmonary artery remodeling after endothelial cell damage. Am J Respir Cell Mol Biol 45:62-71 (2011). IHC-P; Mouse.Read more (PubMed: 20813993) »

See 1 publication for this product

Publishing research using ab5691? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"